A randomized trial of methadone initiation prior to release from incarceration

Substance Abuse

Volumn 33, Issue 1, 2012, Pages 19-29

  McKenzie, Michelle ^a,b   Zaller, Nickolas ^a,b   Dickman, Samuel L ^a,b   Green, Traci C ^a,b   Parihk, Amisha ^a,b   Friedmann, Peter D ^a,b   Rich, Josiah D ^a,b  

^a BROWN UNIVERSITY   (United States)

^b Center for Prisoner Health and Human Rights   (United States)

Author keywords

HIV prevention; incarceration; medication assisted treatment; methadone

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

ADDICTION; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEROIN DEPENDENCE; HUMAN; MALE; METHODOLOGY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PRISONER; RANDOMIZED CONTROLLED TRIAL; STATISTICS;

ADULT; ANALGESICS, OPIOID; FEMALE; FOLLOW-UP STUDIES; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PRISONERS; SUBSTANCE-RELATED DISORDERS;

EID: 84856927570     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2011.609446     Document Type: Article

References (42)

1. West H. Prison inmates at midyear 2009: statistical tables. In: Bureau of Justice Statistics: Statistical Tables. Washington, DC: Bureau of Justice; June 2010. NCJ 230113. Available at: http://bjs.ojp.usdoj.gov/index.cfm?ty= pbdetail&iid=2200. Accessed December 13, 2011.
2. Walmsley R. World Prison Opulation List. 8th ed. London: Kings College of London. International Centre for Prison Studies Web site. Available at: http://www.kcl.ac.uk/depsta/law/research/icps/downloads/world-prison-popseventh. pdf. Accessed December 13, 2011.
3. Drucker E. Drug prohibition and public health: 25 years of evidence. Public Health Rep. 1999;114:14-29.
4. Greifinger R. Thirty years since estelle v. gamble. In: Greifinger R, ed. Public Health Behind Bars: From Prisons to Communities. New York: Springer; 2007:1-12.
5. Mumola C, Karberg J. Drug Use and Dependence, State and Federal Prisoners, 2004. Washington, DC: US Department of Justice; 2006. Bureau of Justice Statistics Special Report (NCJ 213530).
6. Rich JD, Boutwell AE, Shield DC, et al. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health. 2005;82:411-419.
7. Hammett TM. HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response. Am J Public Health. 2006;96:974-978.
8. Nurco DN, Hanlon TE, Kinlock TW. Recent research on the relationship between illicit drug use and crime. Behav Sci Law. 1991;9:221-242.
9. Hanlon TE, Nurco DN, Kinlock TW, Duszynski KR. Trends in criminal activity and drug use over an addiction career. Am J Drug Alcohol Abuse. 1990;16:223-238.
10. Nurco DN, Stephenson PE, Hanlon TE. Aftercare/ relapse prevention and the self-help movement. Int J Addict. 1990;25:1179-1200.
11. Inciardi JA, Needle RH. Editors' introduction: HIV/AIDS interventions for out-of-treatment drug users. J Psychoactive Drugs. 1998;30:225-229.
12. Weatherburn D, Lind B. Heroin harm minimization: do we really have to choose between law enforcement and treatment? New South Wales Crime Justice Bull. 1999;46:1-11.
13. Dolan K, Hall, Wodak A. The provision of methadone within prison settings. In: Ward J, Mattick R, HallW, eds. Methadone Maintenance Treatment and other Opioid Replacement Therapies. Sydney, Australia: Harwood Academic Publishers; 1998.
14. Bick J. HIV and viral hepatitis in corrections: a public health opportunity. In: Greifinger R, ed. Public Health Behind Bars: From Prisons to Communities. New York: Springer; 2007:103-126.
15. Rich JD, McKenzie M, Shield DC, et al. Linkage with methadone treatment upon release from incarceration: a promising opportunity. J Addict Dis. 2005;24:49-59.
16. Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD.Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105:83-88.
17. McKenzie M, Nunn A, Zaller ND, Bazazi AR, Rich JD. Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice. J Opioid Manag. 2009;5:219-227.
18. Zaller ND, Holmes L, Dyl AC, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008;19:522-531.
19. Dole VP,Robinson JW,Orraca J, Towns E, Searcy P, Caine E. Methadone treatment of randomly selected criminal addicts. N Engl J Med. 1969; 280:1372-1375.
20. Sees KL, Delucchi KL, Masson C, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence. JAMA. 2000;283:1303-1310.
21. Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health. 2001;91:774-780.
22. Sorrensen J, Copeland A. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59:17-31.
23. Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O'Grady KE. A randomized clinical trial ofmethadone maintenance for prisoners: results at 12 months postrelease. J Subst Abuse Treat. 2009;37:277-285.
24. Kinlock TW, Gordon MS, Schwartz RP, O'Grady KE. A study of methadone maintenance for male prisoners: 3 month post-release outcomes. Crim Justice Behav. 2008;35:34-47.
25. Kinlock TW, Gordon MS, Schwartz RP, O'Grady K, Fitzgerald TT,Wilson M. A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release. Drug Alcohol Depend. 2007;91:220-227.
26. Lobmaier PP, Kunoe N, Gossop M, Katevoll T, Waal H. Naltrexone implants compared to methadone: outcomes six months after prison release. Eur Addict Res. 2010;16:139-145.
27. Magura S, Rosenblum A, Lewis C, Joseph H. The effectiveness of in-jail methadone maintenance. J Drug Issues. 1993;23:75-99.
28. Gordon MS, Kinlock TW, Schwartz RP, O'Grady KE. A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release. Addiction. 2008;103:1333-1342.
29. Harris A, Selling D, Luther C, et al. Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort. Subs Abuse. 2012;33:70-75.
30. Dolan KA, Shearer J, White B, Zhou J, Kaldor J, Wodak AD. Four-year follow-up of imprisonedmale heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection. Addiction. 2005;100:820-828.
31. Kreek MJ.Rationale formaintenance pharmacotherapy of opiate dependence. Res Publ Assoc Res Nerv Ment Dis. 1992;70:205-230.
32. Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann N Y Acad Sci. 2000;909:186-216.
33. Gerra G, Ferri M, Polidori E, Santoro G, Zaimovic A, Sternieri E. Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables. J Subst Abuse Treat. 2003;25:1-8.
34. Dolan KA, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak AD. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system. Drug Alcohol Depend. 2003;72:59-65.
35. Gottheil E, Sterling RC, Weinstein SP. Diminished illicit drug use as a consequence of long-term methadone maintenance. J Addict Dis. 1993;12:45-57.
36. Busch M, Haas S, Weigl M, Wirl C. Long term substitution treatment (maintenance treatment) of opioid dependent persons. GMS Health Technol Assess. 2007;3:Doc04.
37. Harwood HJ, Hubbard RL, Collins JJ, Rachel JV. The costs of crime and the benefits of drug abuse treatment: a cost benefit analysis using TOPS data. In: Leukefeld CG, Tims FM, eds. Compulsory Treatment of Drug Abuse: Research and Clinical Practice. NIDA Research Monograph 86. Rockville, MD: US Department of Health and Human Services; 1988:209-235.
38. Tomasino V, Swanson AJ, Nolan J, Shuman HI. The Key Extended Entry Program (KEEP): a methadone treatment program for opiate-dependent inmates. Mt Sinai J Med. 2001;68:14-20.
39. McKenzie M, Macalino G, McClung C, Shield DC, Rich JD. Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program. JOpioid Manag. 2005;1:147-151.
40. Lipton D. Correctional drug abuse treatment in the United States: an overview. In: Leukefeld C, Tims F, eds. Drug Abuse Treatment in Prisons and Jails. National Institute on Drug Abuse Monograph Series. Washington, DC: US Department of Health and Human Services; 1992: 8-30.
41. Gore SM, Bird AG, Burns SM, Goldberg DJ, Ross AJ, MacGregor J. Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ. 1995;310:293-296.
42. Mark TL, Woody GE, Juday T, Kleber HD. The economic costs of heroin addiction in the United States. Drug Alcohol Depend. 2001;61:195-206.